GSK to buy Sierra Oncology for $1.9bn
14-04-2022
Bausch & Lomb looks to protect patents in eyedrop lawsuit
26-10-2021
Bausch settles $300m antitrust case over diabetes drug price hikes
13-09-2021
OleksandrShnuryk / Shutterstock.com
Nutritional supplements manufacturer Pharmavite has filed an antitrust suit against Bausch & Lomb and GlaxoSmithKline (GSK), claiming that they are filing sham patent litigation related to its “PreserVision” products
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Pharmavite, Bausch & Lomb, GSK, patents, monopoly, generics
